Treatment of severe bacteroides infections with parenteral clindamycin
Haldane, E.V.; Van Rooyen, C.E.
Canadian Medical Association Journal 107(12): 1177-1181
1972
ISSN/ISBN: 0008-4409 PMID: 4638419 Document Number: 47376
Clindamycin, by intravenous or intramuscular administration, was used in the treatment of 18 patients seriously ill with infections due to bacteroides organisms. In 17 cases there was a rapid favourable clinical response to treatment. No serious toxic effects were observed. This study appears to confirm previous in vitro evidence that clindamycin is presently the antibiotic of choice for such infections.
Document emailed within 1 workday
Related Documents
Bubrick, M.P.; Heim-Duthoy, K.L.; Yellin, A.E.; Berne, T.V.; Heseltine, P.N.; Appleman, M.D.; Cocchetto, D.M.; Matzke, G.R. 1990: Ceftazidime/clindamycin versus tobramycin/clindamycin in the treatment of intra-abdominal infections American Surgeon 56(10): 613-617Iglauer, E.; Wieser, O. 1973: Parenteral treatment of severe bronchopulmonary infections using trimethoprim and sulfamethoxazole Wiener Medizinische Wochenschrift 123(20): 322-323
Shimazaki, C.; Inaba, T.; Murakami, S.; Oku, N.; Itoh, K.; Ura, Y.; Nakagawa, M.; Fujita, N. 1990: Effect of combination therapy with carumonam and clindamycin on severe infections in patients with hematologic malignancies Japanese Journal of Antibiotics 43(8): 1402-1406
Tsuda, S.; Tanaka, S.; Nakagawa, H.; Nishigaki, H.; Okuda, T.; Horiike, S.; Taniwaki, M.; Misawa, S.; Inazawa, J.; Abe, T. 1989: Clinical evaluation of a combination therapy with aztreonam and clindamycin for severe infections in leukemia and related disorders Japanese Journal of Antibiotics 42(9): 1926-1937
Urabe, A.; Takaku, F.; Mizoguchi, H.; Nomura, T.; Aoki, N.; Yamaguchi, H.; Mutoh, Y.; Miura, Y.; Toyama, K.; Hirashima, K. 1990: Combination therapy with aztreonam and clindamycin on severe infections accompanying neutropenic patients with hematological disorders Japanese Journal of Antibiotics 43(10): 1713-1722
Sofianou, D.; Douboyas, J.; Papapanagiotou, J.; Paradelis, A.G. 1982: Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin Methods and Findings in Experimental and Clinical Pharmacology 4(3): 173-177
Bowman, S.; Gold, M.; Nasir, A.; Vamvakias, G. 2005: Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study Journal of Drugs in Dermatology: Jdd 4(5): 611-618
Schumer, W. 1971: Clindamycin in the treatment of soft tissue infections Current Therapeutic Research 13(7): 419-426
Verger, P.; Guillard, J.M. 1972: Treatment trials with clindamycin of infections in young children Bordeaux Medical 5(20): 2783-2788
Cordero-Laurent, E.; Rodríguez, C.; Rodríguez-Cavallini, E.; Gamboa-Coronado, M.M.; Quesada-Gómez, C. 2012: Resistance of Bacteroides isolates recovered among clinical samples from a major Costa Rican hospital between 2000 and 2008 to ß-lactams, clindamycin, metronidazole, and chloramphenicol Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 25(4): 261-265
Herman, G.; Cohen, A.W.; Talbot, G.H.; Coghlan, R.; Faidley-Mangen, P.; MacGregor, R.R. 1986: Cefoxitin versus clindamycin and gentamicin in the treatment of postcesarean section infections Obstetrics and Gynecology 67(3): 371-376
Marasca, C.; Annunziata, M.Carmela.; Villani, A.; Volpe, S.; Marasca, D.; Fabbrocini, G. 2019: Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study Journal of Drugs in Dermatology: Jdd 18(5): 437-438
Shyr, Y.M.; Lui, W.Y.; Su, C.H.; Wang, L.S.; Liu, C.Y. 1995: Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections Zhonghua Yi Xue Za Zhi 56(2): 102-108
Kumada, T.; Tagaya, S.; Watanabe, H.; Shimizu, K. 1977: Clinical experience with parenteral clindamycin Japanese Journal of Antibiotics 30(1): 7-12
1977: Clindamycin and lincomycin: oral and parenteral therapy JAMA 237(14): 1482-1484
Callender, V.D. 2012: Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne Journal of Drugs in Dermatology: Jdd 11(5): 643-648
Poularas, J.; Giamarellou, H.; Vlachos, G.; Theakou, R.; Patoulis, J.; Lekakos, N.; Stavridis, J.; Sfikakis, P. 1988: The treatment of gynaecological and intra-abdominal infections: a comparative study of cefotetan versus netilmicin plus clindamycin Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 7(4): 253-255
Cook-Bolden, F.E. 2012: Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel Journal of Drugs in Dermatology: Jdd 11(4): 455-459
Andrieu, J.; Kwantes, M.; Rey, A. 1976: Bacteroides infections La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 52(25-28): 1529-1535
Bazhenov, L.G.; Iskhakova, K.I. 1983: Bacteroides infections in surgery Vestnik Khirurgii Imeni I. I. Grekova 130(3): 120-122